Literature DB >> 19581305

Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning.

Yung-Ching Chien1, David L Masica, Jeffrey J Gray, Sarah Nguyen, Hojatollah Vali, Marc D McKee.   

Abstract

Calcium oxalate dihydrate (COD) mineral and the urinary protein osteopontin/uropontin (OPN) are commonly found in kidney stones. To investigate the effects of OPN on COD growth, COD crystals were grown with phosphorylated OPN or a polyaspartic acid-rich peptide of OPN (DDLDDDDD, poly-Asp(86-93)). Crystals grown with OPN showed increased dimensions of the {110} prismatic faces attributable to selective inhibition at this crystallographic face. At high concentrations of OPN, elongated crystals with dominant {110} faces were produced, often with intergrown, interpenetrating twin crystals. Poly-Asp(86-93) dose-dependently elongated crystal morphology along the {110} faces in a manner similar to OPN. In crystal growth studies using fluorescently tagged poly-Asp(86-93) followed by imaging of crystal interiors using confocal microscopy, sectoral (compositional) zoning in COD was observed resulting from selective binding and incorporation (occlusion) of peptide exclusively into {110} crystal sectors. Computational modeling of poly-Asp(86-93) adsorption to COD {110} and {101} surfaces also suggests increased stabilization of the COD {110} surface and negligible change to the natively stable {101} surface. Ultrastructural, colloidal-gold immunolocalization of OPN by transmission electron microscopy in human stones confirmed an intracrystalline distribution of OPN. In summary, OPN and its poly-Asp(86-93) sequence similarly affect COD mineral growth; the {110} crystallographic faces become enhanced and dominant attributable to {110} face inhibition by the protein/peptide, and peptides can incorporate into the mineral phase. We, thus, conclude that the poly-Asp(86-93) domain is central to the OPN ability to interact with the {110} faces of COD, where it binds to inhibit crystal growth with subsequent intracrystalline incorporation (occlusion).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581305      PMCID: PMC2749123          DOI: 10.1074/jbc.M109.021899

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  Role of molecular charge and hydrophilicity in regulating the kinetics of crystal growth.

Authors:  S Elhadj; J J De Yoreo; J R Hoyer; P M Dove
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-07       Impact factor: 11.205

2.  The importance of a clean face: the effect of different washing procedures on the association of Tamm-Horsfall glycoprotein and other urinary proteins with calcium oxalate crystals.

Authors:  Rosemary Lyons Ryall; Phulwinder K Grover; Lauren A Thurgood; Magali C Chauvet; David E Fleming; Wilhelm van Bronswijk
Journal:  Urol Res       Date:  2007-02-03

3.  Structure prediction of protein-solid surface interactions reveals a molecular recognition motif of statherin for hydroxyapatite.

Authors:  Kosta Makrodimitris; David L Masica; Eric T Kim; Jeffrey J Gray
Journal:  J Am Chem Soc       Date:  2007-10-12       Impact factor: 15.419

4.  Modulation of calcium oxalate crystallization by linear aspartic acid-rich peptides.

Authors:  Lijun Wang; S Roger Qiu; William Zachowicz; Xiangying Guan; James J Deyoreo; George H Nancollas; John R Hoyer
Journal:  Langmuir       Date:  2006-08-15       Impact factor: 3.882

5.  Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide.

Authors:  Bernd Grohe; Jason O'Young; D Andrei Ionescu; Gilles Lajoie; Kem A Rogers; Mikko Karttunen; Harvey A Goldberg; Graeme K Hunter
Journal:  J Am Chem Soc       Date:  2007-11-10       Impact factor: 15.419

6.  Calcium oxalate crystals in fetal bovine serum: implications for cell culture, phagocytosis and biomineralization studies in vitro.

Authors:  Claudio E Pedraza; Yung-Ching Chien; Marc D McKee
Journal:  J Cell Biochem       Date:  2008-04-01       Impact factor: 4.429

7.  Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals.

Authors:  Adam Taller; Bernd Grohe; Kem A Rogers; Harvey A Goldberg; Graeme K Hunter
Journal:  Biophys J       Date:  2007-05-11       Impact factor: 4.033

8.  Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured renal cells.

Authors:  Phulwinder K Grover; Lauren A Thurgood; David E Fleming; Wilhelm van Bronswijk; Tingting Wang; Rosemary L Ryall
Journal:  Am J Physiol Renal Physiol       Date:  2007-12-12

9.  High calcium concentration and calcium oxalate crystals cause significant inaccuracies in the measurement of urinary osteopontin by enzyme linked immunosorbent assay.

Authors:  Lauren A Thurgood; Phulwinder K Grover; Rosemary Lyons Ryall
Journal:  Urol Res       Date:  2008-05-14

Review 10.  Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.

Authors:  Christian C Kazanecki; Dana J Uzwiak; David T Denhardt
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

View more
  20 in total

1.  The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells.

Authors:  Lauren A Thurgood; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2011-09-20

2.  In situ flow cell platform for examining calcium oxalate and calcium phosphate crystallization on films of basement membrane extract in the presence of urinary 'inhibitors'.

Authors:  Cary A Kuliasha; Douglas Rodriguez; Archana Lovett; Laurie B Gower
Journal:  CrystEngComm       Date:  2020-02-05       Impact factor: 3.545

3.  Renal epithelial cell injury and its promoting role in formation of calcium oxalate monohydrate.

Authors:  Jian-Ming Ouyang; Xiu-Qiong Yao; Jin Tan; Feng-Xin Wang
Journal:  J Biol Inorg Chem       Date:  2010-12-03       Impact factor: 3.358

4.  Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine.

Authors:  Bernd Grohe; Brian P H Chan; Esben S Sørensen; Gilles Lajoie; Harvey A Goldberg; Graeme K Hunter
Journal:  Urol Res       Date:  2011-01-14

5.  ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.

Authors:  Valentin David; Aline Martin; Anne-Marie Hedge; Marc K Drezner; Peter S N Rowe
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-22

6.  Face-specific incorporation of osteopontin into urinary and inorganic calcium oxalate monohydrate and dihydrate crystals.

Authors:  Lauren A Thurgood; Alison F Cook; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2010-07-22

7.  Partial high-resolution structure of phosphorylated and non-phosphorylated leucine-rich amelogenin protein adsorbed to hydroxyapatite.

Authors:  David L Masica; Jeffrey J Gray; Wendy J Shaw
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2011-07-21       Impact factor: 4.126

Review 8.  Biominerals--hierarchical nanocomposites: the example of bone.

Authors:  Elia Beniash
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011 Jan-Feb

Review 9.  Biomolecular mechanism of urinary stone formation involving osteopontin.

Authors:  Kenjiro Kohri; Takahiro Yasui; Atsushi Okada; Masahito Hirose; Shuzo Hamamoto; Yasuhiro Fujii; Kazuhiro Niimi; Kazumi Taguchi
Journal:  Urol Res       Date:  2012-11-06

10.  Revisiting the Fundamentals in the Design and Control of Nanoparticulate Colloids in the Frame of Soft Chemistry.

Authors:  Vuk Uskoković
Journal:  Rev J Chem       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.